- The CSP exam uses a criterion-referenced cut score set by a standard-setting panel, not a fixed 70% rule.
- Only 100 of the 125 questions count; the other 25 are unscored pretest items you can't identify.
- The 2025 pass rate was 61%, down from 69% in 2024 and 82% in 2023.
- Clinical Management is 65% of the exam, so your score there largely determines whether you clear the cut score.
How CSP Scoring Actually Works
The Certified Specialty Pharmacist (CSP) exam, administered through the Specialty Pharmacy Certification Board (SPCB), does not use a simple percentage cutoff like "70% to pass." Instead, it's scored using a criterion-referenced method: a standard-setting panel of subject matter experts reviews every scored item and determines how many correct answers demonstrate minimum competency for safe, independent specialty pharmacy practice. That number becomes the cut score for that exam form.
Because SPCB reports results as raw scores rather than scaled scores or percentages, your score report tells you how many of the 100 scored items you answered correctly, delivered immediately when you finish your session at a PSI testing center or via Live Remote Proctoring. There's no waiting period for results, but there's also no universal "magic number" you can memorize in advance, because the cut score is tied to the specific difficulty of the item set on your form.
Why There's No Published "Passing Score"
SPCB does not publish an exact raw-score cut point publicly, which is standard practice for NCCA-accredited, criterion-referenced credentials. This is intentional: publishing a fixed number would let candidates game the exam around a threshold rather than build genuine clinical competence in specialty pharmacy practice. It also allows the standard-setting panel to recalibrate slightly between item sets to keep the exam fair as pretest questions rotate in and out.
What this means practically for anyone researching CSP passing score 2026 requirements: you should stop searching for a percentage and start focusing on what the exam actually tests. The four domains and their weights, described in more detail in the CSP Exam Domains 2026 guide, are the real blueprint for where your preparation time should go.
Key Takeaway
Don't waste study time trying to reverse-engineer an exact cut score. Instead, treat every domain as if you need strong, well-rounded mastery, since the panel sets the bar based on competent practice, not memorized trivia.
What the Pass Rate Trend Tells You
SPCB reported a 61% pass rate among 312 candidates tested in 2025, down from 69% in 2024 and 82% in 2023. That three-year decline is worth paying attention to. It doesn't necessarily mean the cut score itself is rising every year - criterion-referenced exams are designed to hold competency standards steady - but it does suggest the candidate pool, item difficulty, or both have shifted since the exam was rebuilt on the 2023 job analysis for exams administered after January 1, 2024.
For a deeper breakdown of these numbers and what they mean for your odds, see the CSP Pass Rate 2026 data analysis. If you're trying to gauge overall exam difficulty before you commit to the $550 US application fee, the CSP exam difficulty guide puts the pass-rate trend in context alongside content depth and time pressure.
| Year | Pass Rate | Context |
|---|---|---|
| 2023 | 82% | Prior job analysis cycle |
| 2024 | 69% | First full year under 2023 job analysis |
| 2025 | 61% | 312 candidates tested |
With 2,004 active certificants and a 95% retention rate, once pharmacists clear the initial exam, they overwhelmingly maintain the credential through recertification. The harder step is passing the first time - which is exactly why understanding domain weighting matters more than chasing a mythical passing percentage.
Domain Weighting and the Score You Need
The 100 scored questions are distributed across four domains, and because the exam is criterion-referenced across the whole form rather than domain-by-domain, a strong showing in the heaviest domain has an outsized effect on whether you clear the cut score.
Domain 2: Clinical Management (65%)
This domain dominates the exam and should dominate your study time. It covers therapeutic decision-making, monitoring parameters, and disease-specific management across the specialty drug landscape.
- Inflammatory diseases account for 20% of exam content - the single largest disease-state slice
- Oncology and hematology follow at 15%
- Multiple sclerosis represents 10%
Domain 1: Intake (12%)
Covers referral processing, benefits verification, and initial patient assessment workflows unique to specialty pharmacy onboarding.
Domain 3: Fulfillment (12%)
Covers dispensing logistics, cold-chain and specialty distribution requirements, and coordination between prescriber, payer, and pharmacy.
Domain 4: Outcomes (11%)
Covers adherence monitoring, clinical outcomes tracking, and patient support program evaluation.
Because Clinical Management alone represents nearly two-thirds of the scored items, a candidate who is weak on inflammatory disease management, oncology/hematology regimens, or MS therapies is fighting an uphill battle no matter how strong Intake, Fulfillment, and Outcomes performance is. For the full breakdown of subtopics inside each domain, the CSP Exam Domains 2026 guide walks through every content area in depth.
Question Format and the 25 Unscored Items
The exam consists of 125 multiple-choice questions delivered over a 2-hour session, offered in English only and built specifically around US specialty pharmacy practice. Of those 125 items, only 100 are scored - the remaining 25 are unscored pretest questions SPCB uses to evaluate future exam content. You will not be told which items are scored and which are pretest, so every question deserves your full attention.
The exam runs at PSI testing centers across the US and Canada, or via Live Remote Proctoring, with the important caveat that no breaks are permitted under remote proctoring. If you're deciding between formats, factor in your own stamina for a continuous 2-hour, 125-item session with no pause option.
Registration, Fees, and What Happens If You Fail
Before scoring even enters the picture, you need to clear eligibility: a BS Pharm or PharmD, an active unrestricted pharmacist license in the US or Canada, 3,000 hours of specialty pharmacy practice within the previous four years, and 30 hours of ACPE-accredited specialty pharmacy continuing education within the previous two years, plus Code of Conduct and accuracy attestations. Full detail on qualifying pathways, including how residency hours count toward the practice requirement, is covered in the CSP Requirements 2026 guide.
Initial certification costs $550 in the US and $650 in Canada, with a $50 discount available to NASP members. If you don't clear the cut score on your first attempt, retesting costs $425 US or $525 Canada - and you must wait two full testing windows before you're eligible to sit again, since the exam only runs in six two-month testing windows per year with applications closing on the 15th of the prior month. That waiting period makes a failed attempt costly in both money and time, which is exactly why understanding the cut score mechanics matters before you register. The CSP Certification Cost 2026 breakdown covers every fee tier, and the CSP Exam Dates 2026 guide maps out the testing windows so a failed attempt doesn't cost you an extra six months of waiting.
Key Takeaway
A failed attempt isn't just a $425-$525 retest fee - it's a mandatory two-testing-window wait. Treat your first attempt as the one that matters and prepare accordingly rather than planning to "test and learn."
Building a Study Plan Around the Cut Score
Since the passing standard is set against the full 100-item scored pool rather than domain-by-domain minimums, your preparation should mirror the exam's own weighting. That means allocating roughly two-thirds of your study time to Clinical Management, with particular depth on inflammatory disease management, oncology/hematology, and multiple sclerosis, before spreading the remainder across Intake, Fulfillment, and Outcomes.
Clinical Management Core
- Inflammatory disease treatment pathways and monitoring
- Oncology/hematology regimen management
- Multiple sclerosis therapy protocols
Intake and Fulfillment
- Referral intake and benefits verification workflows
- Specialty distribution, cold-chain, and dispensing logistics
Outcomes and Integration
- Adherence and outcomes tracking methods
- Cross-domain practice items under timed conditions
Full-Length Timed Review
- Simulate the 125-question, 2-hour format
- Review weak areas identified in practice sessions
A structured, weighted approach like this is covered step-by-step in the CSP Study Guide 2026, and running full-length practice sessions on our practice test platform is the closest way to simulate the pacing pressure of the real 2-hour session before exam day. Because you can't tell scored items from the 25 unscored pretest questions, timed practice on realistic CSP practice questions is more valuable than untimed flashcard review alone.
Frequently Asked Questions
SPCB does not publish a fixed passing percentage. The exam uses criterion-referenced scoring, and a standard-setting panel sets the cut score based on the specific 100 scored items on your form. Results are reported as raw scores immediately after your session.
No, but you won't know which 25 of the 125 questions are unscored, so you should answer every item as if it counts toward your final score.
There's no published number, since the cut score is determined by a standard-setting panel and varies by form difficulty. Given the 2025 pass rate of 61%, aim to master content deeply rather than calculate an exact missable-question count.
You must wait two full testing windows before retesting, and pay a retest fee of $425 US or $525 Canada. With only six two-month testing windows per year, a failed attempt can delay certification by several months.
Clinical Management, which makes up 65% of the exam. Within it, inflammatory diseases (20%), oncology/hematology (15%), and multiple sclerosis (10%) carry the heaviest disease-state weighting.